Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 19, 2016
FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection of participants during the conduct of clinical research. Misconduct in clinical research, including, but not limited to the falsification ...
read more
The FDA has posted warning letters to five companies who produce products labeled as homeopathic for significant violations of CGMP regulations.
read more
Friday, September 21, 2018
The FDA has issued a warning letter to Pharmaceutical Laboratories and Consultants regarding several violations at the Illinois-based lab, including the presence of a microbrewery in its drug testing area.
read more
Wednesday, October 23, 2019
The FDA has issued a warning letter to Jiangsu NHWA.
read more
Monday, December 18, 2023
Checkpoint Therapeutics, Inc. disclosed that the FDA issued a Complete Response Letter (CRL) in connection with the cosibelimab biologic license application (BLA) intended for the treatment of individuals with metastatic or locally advanced cutaneous...
read more
Monday, November 12, 2018
The FDA announced the U.S. Marshals Service has conducted a mass seizure of FDA-regulated products being held under insanitary conditions in which they were exposed to widespread rodent, insect and live animal infestation.
read more
Wednesday, August 29, 2018
The FDA issued a Federal Register notice proposing not to include three bulk drug substances on the list of bulk drug substances that outsourcing facilities may use in compounding under section 503B of the 503B bulks list.
read more
The U.S. FDA announced it is requesting $7.2 billion as part of the President's fiscal year (FY) 2025 proposed budget.
read more
The FDA has published a warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require ...
read more
Wednesday, December 27, 2023
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
read more
Wednesday, August 28, 2019
The FDA is reminding patients and health care professionals not to use drug products intended to be sterile made by Pacifico National, a facility doing business as AmEx Pharmacy.
read more
The U.S. Food & Drug Administration (FDA) scientists recently discovered an inaccuracy in certain data provided to the agency by the IQVIA National Sales Perspectives database, including data on certain opioid drug products.
read more
Wednesday, September 25, 2019
Certara® announced the FDA has renewed licenses for Synchrogenix’s electronic Common Technical Document review software, GlobalSubmit REVIEW™ and GlobalSubmit VALIDATE™.
read more
DILIsym Services announced the FDA has renewed its multi-seat license for the company’s flagship quantitative systems toxicology modeling software, DILIsym®.
read more
The FDA is warning consumers and health care professionals about certain hand sanitizer products, including are labeled to contain ethanol or isopropyl alcohol but have tested positive for 1-propanol contamination.
read more